Biotech companies are difficult to evaluate or analyze due to the speculative nature of their technologies and due to the breadth of knowledge, experience,...
Last week, the major indices recorded their second consecutive week of losses (the third for the tech-heavy Nasdaq) as eye-popping data revealed that inflation...